Editor's Note Private equity ownership drives up colonoscopy prices without delivering better patient outcomes, according to a large retrospective analysis. While independent and private equity-acquired gastroenterology practices show no significant difference in quality, prices at private equity practices rose sharply, especially in highly consolidated markets. The study, published in JAMA…

Read More

Editor's Note A new blood test shows promise in detecting colorectal cancer—the second leading cause of cancer deaths in the US—but was less effective at identifying precancerous polyps, according to a June 2 announcement from Kaiser Permanente. Not yet approved by the US Food and Drug Administration, the test is…

Read More

Editor's Note Routine colonoscopy surveillance after polyp removal is safe for adults over 75 and should not be ruled out based on age alone, according to a new study from Kaiser Permanente published on May 27 in Clinical Gastroenterology and Hepatology. The research, conducted as part of the National Cancer…

Read More

Editor's Note Research published in Nature reveals that DNA damage caused by colibactin-producing gut bacteria is far more prevalent in younger patients with colorectal cancer, NBC News reports, suggesting a key factor behind the disturbing rise in cases among people under 40.  According to the April 23 article, researchers from…

Read More

Editor's Note The American College of Gastroenterology (ACG) is warning that millions of Americans could lose access to essential colorectal cancer (CRC) screenings if the Supreme Court rules against the role of the US Preventive Services Task Force (USPSTF) in guiding preventive care coverage. According to the organization’s March 7…

Read More

Editor's Note Individuals with negative colonoscopy screening (NCS) results face significantly lower long-term risk of colorectal cancer (CRC) incidence and mortality, suggesting the recommended 10-year rescreening interval could be safely extended for low-risk populations, according to a study published in JAMA Oncology. Healio reported on the results January 15. As…

Read More

Editor's Note Stool-based testing strategies could significantly reduce the number of colonoscopies required for post-polypectomy colorectal cancer (CRC) surveillance while maintaining equivalent long-term outcomes in cancer incidence and mortality, according to research published August 30 in Gastroenterology. Conducted in the Netherlands, the cross-sectional observational study compared three stool tests—multitarget stool…

Read More

Editor's Note Odin Medical, a subsidiary of Olympus Corporation, received Food and Drug Administration (FDA) 510(k) clearance for its cloud-based AI technology, the CADDIE™ computer-aided detection device, PRNewswire September 5 reports. Designed to assist gastroenterologists in detecting colorectal polyps during colonoscopy, the AI-powered system analyzes real-time video footage and alerts…

Read More

Editor's Note A new study reveals a worrying trend: While colorectal cancer rates have been decreasing in older adults, they are significantly rising among children and teens, Healthline May 9 reports. The findings from this study will be presented on Monday, May 20, at the Digestive Disease Week conference in…

Read More

Editor's Note By putting the patient into deeper sedation during colonoscopy, propofol could help doctors find difficult-to-spot, potentially cancerous “serrated” polyps, according to a study published April 17 in Anesthesiology. As an alternative to moderate, “conscious” sedation, propofol facilitates a more thorough exam that is more likely to identify serrated…

Read More